本報告已在2012年03月01日停止出版。
更改為出版
Personalized Medicine Market Analysis
出版日期 : 2012年01月
商品編碼: 228193
個人化醫療的登場替醫療業界帶來巨大變革。個人化醫療的歷史尚短，不過，預料在美國2009-2015年將以年平均12%成長，且將產生波及到新參與和其他國家、對相關產業的影響等各種現象。
本報告，調查美國以及其他國家的個人化醫療產業，彙整市場促進・抑制因素、參與企業・產業的概要、對其他國家的波及、競爭狀態和對相關產業的影響等內容，由下列摘要形式闡述。
第1章 分析師的見解
第2章 分析方式
第3章 個人化醫療市場：簡介
第4章 市場促進・抑制因素
第5章 美國的個人化醫療市場
第6章 市場參與者
- 製藥企業
- 診斷企業
- 技術提供企業
- 醫療提供企業
- 政府
第7章 新開拓市場
第8章 個人化治療用藥品・處置
第9章 策略合作
第10章 近年的發展
第11章 法規環境
第12章 競爭情勢
- 藥品・生物科技企業
- IT・情報科學企業
- 診斷企業
- 分析工具企業
- 壽險企業
圖表一覽
Abstract
The era of personalized medicine is set to revolutionize the healthcare
industry. With the expansion of our knowledge of genetics and molecular
biology, personalized approach to medical care is increasingly becoming
important. While still in the early stages, personalized medicine is steadily
emerging as the new healthcare paradigm. In fact, this paradigm not only
promises the improvement of an individual' s treatment outcome and reduces
healthcare expenditure; but is set to transform the biopharmaceutical and
molecular diagnostics markets in the coming years.
According to our new research report “Personalized Medicine Market
Analysis”, the U.S. market for personalized medicine is anticipated
to grow at a CAGR of around 12% during 2009-2015. Growth will be driven by
factors, such as treatment costs savings, early detection of diseases, patient
compliance, drug safety, and optimization of therapies.
Presently, the industry as a whole is committed to the development of
personalized medicines and is commanding more resources and fomenting more
corresponding organization change. In fact, strategic alliances, like the
Sanofi-Aventis alliance with Scripps Genomic Medicine, are being formed with
academic and private research institutions as well as small biotech companies
and major pharma companies are increasingly looking for alternative ways to
strengthen their pipelines.
Our report has found that the market is presently dominated by Oncology
applications. However, therapeutic applications of personalized medicines will
extend to new therapy areas in the coming years. Further, the US, Europe,
China, and Japan are the major geographical markets exhibiting healthy growth
rates.
The report provides extensive information and rational analysis of the global
personalized medicine market. It has thoroughly examined current market
trends, industrial developments, and competitive landscape to enable clients
understand the market structure and its progress in coming years. The report
also provides an insight into the segment-wise market trends prevailing at the
regional level to present an overview of the developments taking place in
these segments across the world.
Table of Contents
1. Analyst View
2. Research Methodology
3. Personalized Medicine Market: An Introduction
4. Market Drivers & Restraints
- 4.1 Drivers
- 4.2 Restraints
5. US: Personalized Medicine Market
- 5.1 Market Performance
- 5.2 Market Segmentation
- 5.2.1 Core Segment
- 5.2.2 Personalized Medical Care
- 5.2.3 Nutrition & Wellness
6. Market Participants
- 6.1 Pharmaceutical Companies
- 6.2 Diagnostic Companies
- 6.3 Technology Providers
- 6.4 Healthcare Providers
- 6.5 Government
7. Emerging Markets
- 7.1 Europe
- 7.2 Japan
- 7.3 China
- 7.4 India
8. Personalized Therapeutics Drugs & Treatments
9. Strategic Collaborations
10. Recent Developments
11. Regulatory Environment
12. Competitive Landscape
- 12.1 Pharma/Biotech Companies
- 12.2 IT/Informatics Companies
- 12.3 Diagnostic Companies
- 12.4 Research Tool Companies
- 12.5 Health Insurance Companies
List of Figures:
- Figure 5-1: US - Personalized Medicine Market (Billion US$), 2009 & 2015
- Figure 5-2: US - Personalized Medicine Market by Segment (%), 2009
- Figure 5-3: US - Forecast for Personalized Medicine Market by Segment (%),
2015
- Figure 5-4: US - Personalized Medicine Core Market (Billion US$), 2009 &
2015
- Figure 5-5: US - Personalized Medicine Core Market by Sub-Segment (%), 2009
- Figure 5-6: US - Forecast for Personalized Medicine Core Market by
Sub-Segment (%), 2015
- Figure 5-7: US - Personalized Medical Care Market (Billion US$), 2009 &
2015
- Figure 5-8: US - Personalized Medical Care Market by Sub-Segment (%), 2009
& 2015
- Figure 5-9: US - Personalized Medicine Nutrition & Wellness Market
(Billion US$), 2009 & 2015
- Figure 5-10: US - Personalized Medicine Nutrition & Wellness Market by
Sub-Segment (%), 2009 & 2015
List of Tables:
- Table 8-1: Personalized Medicine for Indication by Therapy and Diagnostics
(2009)
- Table 9-1: Major Collaborations in Personalized Medicine Market
